An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results imply.
The drug Paxlovid – is reserved for use soon after symptoms develop in people at high risk of severe disease.
Pfizer says it halted trials early as the initial results were so positive.
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
